These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 32555031)

  • 1. Report of 2 Pediatric Cases With Li-Fraumeni Syndrome Related Malignancy in a Family.
    Takeoka M; Toyoda H; Hirayama J; Suzuki N; Hanaki R; Amano K; Iwamoto S; Hirayama M
    J Pediatr Hematol Oncol; 2021 May; 43(4):e567-e570. PubMed ID: 32555031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort.
    Mai PL; Best AF; Peters JA; DeCastro RM; Khincha PP; Loud JT; Bremer RC; Rosenberg PS; Savage SA
    Cancer; 2016 Dec; 122(23):3673-3681. PubMed ID: 27496084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SEOM clinical guideline on heritable TP53-related cancer syndrome (2022).
    Sánchez-Heras AB; Ramon Y Cajal T; Pineda M; Aguirre E; Graña B; Chirivella I; Balmaña J; Brunet J;
    Clin Transl Oncol; 2023 Sep; 25(9):2627-2633. PubMed ID: 37133731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TP53 p.R337H is a conditional cancer-predisposing mutation: further evidence from a homozygous patient.
    Giacomazzi J; Selistre S; Duarte J; Ribeiro JP; Vieira PJ; de Souza Macedo G; Rossi C; Czepielewski M; Netto CB; Hainaut P; Ashton-Prolla P
    BMC Cancer; 2013 Apr; 13():187. PubMed ID: 23570263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two TP53 germline mutations in a classical Li-Fraumeni syndrome family.
    van Hest LP; Ruijs MW; Wagner A; van der Meer CA; Verhoef S; van't Veer LJ; Meijers-Heijboer H
    Fam Cancer; 2007; 6(3):311-6. PubMed ID: 17318340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Li-Fraumeni syndrome: report of a clinical research workshop and creation of a research consortium.
    Mai PL; Malkin D; Garber JE; Schiffman JD; Weitzel JN; Strong LC; Wyss O; Locke L; Means V; Achatz MI; Hainaut P; Frebourg T; Evans DG; Bleiker E; Patenaude A; Schneider K; Wilfond B; Peters JA; Hwang PM; Ford J; Tabori U; Ognjanovic S; Dennis PA; Wentzensen IM; Greene MH; Fraumeni JF; Savage SA
    Cancer Genet; 2012 Oct; 205(10):479-87. PubMed ID: 22939227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inherited
    Guha T; Malkin D
    Cold Spring Harb Perspect Med; 2017 Apr; 7(4):. PubMed ID: 28270529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Li Fraumeni Syndrome predisposes to gastro-esophageal junction tumours.
    Tjandra D; Boussioutas A
    Fam Cancer; 2024 Mar; 23(1):29-33. PubMed ID: 38206485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case report: TP53 c.848G>A germline mutation as a possible screening target at initial diagnosis for acute lymphoblastic leukemia.
    Hua F; Hu Y; He GC; Lai SH; He Y; Zhang S; Deng Y; Han Y; Liu XD; Yang K; Zhong HX; Xiao J; Zheng ZZ; Yi H
    Hematology; 2024 Dec; 29(1):2377860. PubMed ID: 39007733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectrum and Excess Risk of Gastrointestinal Tumors in Li-Fraumeni Syndrome.
    Hatton JN; de Andrade KC; Frone MN; Savage SA; Khincha PP
    Clin Gastroenterol Hepatol; 2024 Mar; 22(3):662-665.e1. PubMed ID: 37714395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upper Gastrointestinal Cancer Risk and Surveillance Outcomes in Li-Fraumeni Syndrome.
    Katona BW; Powers J; McKenna DB; Long JM; Le AN; Hausler R; Zelley K; Jennings S; Domchek SM; Nathanson KL; MacFarland SP; Maxwell KN
    Am J Gastroenterol; 2020 Dec; 115(12):2095-2097. PubMed ID: 32969947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Features of Li-Fraumeni Syndrome in Korea.
    Song R; Kong SY; Choi W; Lee EG; Woo J; Han JH; Lee S; Kang HS; Jung SY
    Cancer Res Treat; 2024 Jan; 56(1):334-341. PubMed ID: 37562436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early Cancer Detection in Li-Fraumeni Syndrome with Cell-Free DNA.
    Wong D; Luo P; Oldfield LE; Gong H; Brunga L; Rabinowicz R; Subasri V; Chan C; Downs T; Farncombe KM; Luu B; Norman M; Sobotka JA; Uju P; Eagles J; Pedersen S; Wellum J; Danesh A; Prokopec SD; Stutheit-Zhao EY; Znassi N; Heisler LE; Jovelin R; Lam B; Lujan Toro BE; Marsh K; Sundaravadanam Y; Torti D; Man C; Goldenberg A; Xu W; Veit-Haibach P; Doria AS; Malkin D; Kim RH; Pugh TJ
    Cancer Discov; 2024 Jan; 14(1):104-119. PubMed ID: 37874259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is It Time to Incorporate Liquid Biopsy into High-Risk Cancer Surveillance Protocols in Li-Fraumeni Syndrome?
    Latham A; MacFarland SP; Walsh MF; Maxwell KN; Stadler ZK
    Cancer Discov; 2024 Jan; 14(1):23-25. PubMed ID: 38213298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance imaging and early surgical intervention for improved CNS tumor outcomes in children with Li-Fraumeni syndrome: Children's National Hospital experience and literature review.
    Patel N; Felton K; Bhattacharya S; Almira-Suarez MI; Eze A; Turner J; Keating R; Oluigbo C; Schore RJ; Kilburn L; Packer RJ; Myseros JS; Bornhorst M
    J Neurosurg Pediatr; 2023 Mar; 31(3):258-267. PubMed ID: 36609372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome.
    Kolodziejczak AS; Guerrini-Rousseau L; Planchon JM; Ecker J; Selt F; Mynarek M; Obrecht D; Sill M; Autry RJ; Stutheit-Zhao E; Hirsch S; Amouyal E; Dufour C; Ayrault O; Torrejon J; Waszak SM; Ramaswamy V; Pentikainen V; Demir HA; Clifford SC; Schwalbe EC; Massimi L; Snuderl M; Galbraith K; Karajannis MA; Hill K; Li BK; Walsh M; White CL; Redmond S; Loizos L; Jakob M; Kordes UR; Schmid I; Hauer J; Blattmann C; Filippidou M; Piccolo G; Scheurlen W; Farrag A; Grund K; Sutter C; Pietsch T; Frank S; Schewe DM; Malkin D; Ben-Arush M; Sehested A; Wong TT; Wu KS; Liu YL; Carceller F; Mueller S; Stoller S; Taylor MD; Tabori U; Bouffet E; Kool M; Sahm F; von Deimling A; Korshunov A; von Hoff K; Kratz CP; Sturm D; Jones DTW; Rutkowski S; van Tilburg CM; Witt O; Bougeard G; Pajtler KW; Pfister SM; Bourdeaut F; Milde T
    Neuro Oncol; 2023 Dec; 25(12):2273-2286. PubMed ID: 37379234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo germline TP53 mutation in a pediatric patient with Li-Fraumeni syndrome and diffuse peritoneal mesothelioma.
    Ortaköylü MY; Özdemir Sİ; Dinçaslan H; Taçyıldız N; Ateş U; Ünal AE; Soydal Ç; Fitoz ÖS; Karabulut HG; Ruhi HI; Ünal EC
    Pediatr Blood Cancer; 2024 Aug; 71(8):e31071. PubMed ID: 38773723
    [No Abstract]   [Full Text] [Related]  

  • 18. Embodied risk for families with Li-Fraumeni syndrome: Like electricity through my body.
    Werner-Lin A; Forbes Shepherd R; Young JL; Wilsnack C; Merrill SL; Greene MH; Khincha PP
    Soc Sci Med; 2022 May; 301():114905. PubMed ID: 35367908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenal cortical carcinoma: Paediatric aspects - literature review.
    Dasiewicz P; Moszczyńska E; Grajkowska W
    Pediatr Endocrinol Diabetes Metab; 2024; 30(2):81-90. PubMed ID: 39026485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pleomorphic dermal sarcoma presenting in a child with Li-Fraumeni syndrome: A case report and review of the literature.
    Kim H; Noh H; Shim J; Oh SJ; Lee JH; Lee DY; Park JH
    Pediatr Dermatol; 2024; 41(2):311-314. PubMed ID: 38014598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.